NS
WST icon

NBC Securities’s West Pharmaceutical WST Stock Holding History

NBC Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Buy
12
+1
+9% +$306 ﹤0.01% 2106
2026
Q1 		$2.76K Sell
11
-3
-21% -$746 ﹤0.01% 2260
2025
Q4 		$3.85K Hold
14
– – ﹤0.01% 2264
2025
Q3 		$3.67K Sell
14
-2
-13% -$486 ﹤0.01% 2280
2025
Q2 		$3K Hold
16
– – ﹤0.01% 2257
2025
Q1 		$3K Buy
+16
New +$4.41K ﹤0.01% 1998
2024
Q4 		– Sell
-11
Closed -$3K – 2096
2024
Q3 		$3K Sell
11
-23
-68% -$7.04K ﹤0.01% 1992
2024
Q2 		$11K Buy
34
+1
+3% +$353 ﹤0.01% 1670
2024
Q1 		$13K Buy
33
+25
+313% +$9.25K ﹤0.01% 1612
2023
Q4 		$2K Hold
8
– – ﹤0.01% 2043
2023
Q3 		$3K Buy
+8
New +$3.09K ﹤0.01% 1972

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NBC Securities's WST Position: Q2 2026 in Review

NBC Securities increased its West Pharmaceutical (WST) stake by 9.1% in Q2 2026, buying an estimated $306 and bringing the position to 12 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

NBC Securities first reported a position in WST in Q3 2023 and has held it in 11 quarters since. The position peaked at $13K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • NBC Securities held 12 shares of West Pharmaceutical worth $4.31K as of Q2 2026.
  • NBC Securities bought 1 West Pharmaceutical share in Q2 2026, an estimated $306.
  • West Pharmaceutical made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2106 holding.
  • NBC Securities first reported a position in West Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's West Pharmaceutical position peaked at $13K in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.